Dr. Sidhu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Trancas Street
Napa, CA 94558Phone+1 707-253-7161
Education & Training
- SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2002 - 2005
- Bangalore Medical CollegeClass of 2000
Certifications & Licensure
- CA State Medical License 2018 - 2025
- NY State Medical License 2007 - 2023
- WY State Medical License 2012 - 2014
- WI State Medical License 2005 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 Start of enrollment: 2010 Oct 01
- Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance Start of enrollment: 2011 Oct 28
Publications & Presentations
PubMed
- 16 citationsAttributes of brain metastases from breast and lung cancer.Kyle Hengel, Gurinder Sidhu, Jai Choi, Jeremy Weedon, Emmanuel Nwokedi
International Journal of Clinical Oncology. 2013-06-01 - 7 citationsComplete resolution of bone metastases with pembrolizumab.Gurinder Sidhu, Eric Tam
Japanese Journal of Clinical Oncology. 2019-07-01 - 6 citationsReal-World Evidence of the Top 100 Prescribed Drugs in the USA and Their Potential for Drug Interactions with Nirmatrelvir; Ritonavir.Jacqueline Gerhart, Florin Draica, Michael Benigno, Jo Atkinson, Maya Reimbaeva
The AAPS Journal. 2023-07-20
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: